Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Daiwa Securities Group Inc.

Daiwa Securities Group Inc. grew its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 6.3% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 7,827 shares of the biotechnology company’s stock after acquiring an additional 462 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Axon Enterprise were worth $2,022,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in AXON. Vontobel Holding Ltd. lifted its holdings in shares of Axon Enterprise by 13.1% in the third quarter. Vontobel Holding Ltd. now owns 3,766 shares of the biotechnology company’s stock valued at $749,000 after buying an additional 436 shares during the period. CWM LLC lifted its holdings in shares of Axon Enterprise by 1.8% in the third quarter. CWM LLC now owns 2,669 shares of the biotechnology company’s stock valued at $531,000 after buying an additional 46 shares during the period. AE Wealth Management LLC lifted its holdings in shares of Axon Enterprise by 32.4% in the third quarter. AE Wealth Management LLC now owns 1,775 shares of the biotechnology company’s stock valued at $353,000 after buying an additional 434 shares during the period. IFP Advisors Inc lifted its holdings in shares of Axon Enterprise by 150.2% in the third quarter. IFP Advisors Inc now owns 618 shares of the biotechnology company’s stock valued at $123,000 after buying an additional 371 shares during the period. Finally, Flagship Harbor Advisors LLC lifted its holdings in shares of Axon Enterprise by 28.0% in the third quarter. Flagship Harbor Advisors LLC now owns 1,945 shares of the biotechnology company’s stock valued at $387,000 after buying an additional 425 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $293.80 on Tuesday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. The firm has a market cap of $22.17 billion, a price-to-earnings ratio of 127.74 and a beta of 0.93. The business’s 50-day simple moving average is $301.41 and its 200-day simple moving average is $259.57. Axon Enterprise, Inc. has a 52 week low of $175.37 and a 52 week high of $329.87.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.29. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The firm had revenue of $432.14 million during the quarter, compared to the consensus estimate of $418.97 million. As a group, equities research analysts expect that Axon Enterprise, Inc. will post 2.44 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Argus assumed coverage on Axon Enterprise in a report on Wednesday, March 13th. They issued a “buy” rating and a $380.00 price objective for the company. Barclays upped their target price on Axon Enterprise from $296.00 to $308.00 and gave the company an “overweight” rating in a report on Thursday, February 29th. JMP Securities upped their target price on Axon Enterprise from $250.00 to $285.00 and gave the company a “market outperform” rating in a report on Tuesday, February 6th. The Goldman Sachs Group upped their target price on Axon Enterprise from $297.00 to $339.00 and gave the company a “buy” rating in a report on Wednesday, February 28th. Finally, Robert W. Baird upped their target price on Axon Enterprise from $260.00 to $300.00 and gave the company an “outperform” rating in a report on Thursday, February 22nd. Two analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $312.64.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.